Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Predictions

buy
Biogen Inc.

Start price
Target price
Perf. (%)
€199.36
07.09.22
€300.00
31.12.24
36.69%
30.09.22

Could be very worthwhile Investment >20% year
buy
Merck & Co. Inc.

Start price
Target price
Perf. (%)
€90.50
24.08.22
€120.00
24.08.23
17.79%
08.05.23

Could be worthwhile Investment >10% per year
buy
Gilead Sciences Inc

Start price
Target price
Perf. (%)
€64.74
22.08.22
€80.00
22.08.23
8.80%
23.08.23

Could be worthwhile Investment >10% per year
Fair valuation
High dividend yield expected
buy
Zoetis Inc. A

Start price
Target price
Perf. (%)
€176.92
03.08.22
€190.00
03.08.23
-6.34%
03.08.23

Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
Future proof or reliable business model
buy
Pfizer Inc.

Start price
Target price
Perf. (%)
€49.24
31.07.22
€50.00
31.07.23
-31.05%
22.05.23

Capable Management
Good culture
Innovative
Differentiated customer and product portfolio
buy
Medtronic plc

Start price
Target price
Perf. (%)
€91.39
27.07.22
€100.00
27.07.23
-11.48%
28.07.23

Could be worthwhile Investment >10% per year
Top 10 in its market
Known brand
Future proof or reliable business model
buy
Pfizer Inc.

Start price
Target price
Perf. (%)
€49.74
20.07.22
€55.00
20.07.23
-33.55%
21.07.23

Small challenges to pay loans and raise capital
Innovative
Very small cyclical dependencies
Some uniques
buy
Johnson & Johnson

Start price
Target price
Perf. (%)
€175.60
13.07.22
€168.00
13.07.23
-19.13%
13.07.23

buy
Becton, Dickinson & Co.

Start price
Target price
Perf. (%)
€235.25
13.07.22
€239.00
13.07.23
-1.59%
13.07.23

buy
Medtronic plc

Start price
Target price
Perf. (%)
€88.30
13.07.22
€83.00
13.07.23
-11.66%
13.07.23

buy
Regeneron Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€613.40
10.07.22
€999.00
10.07.23
-6.06%
23.07.22

Could be very worthwhile Investment >20% year
buy
Humana Inc.

Start price
Target price
Perf. (%)
€469.25
07.07.22
-
07.07.23
-14.35%
07.07.23

buy
AbbVie Inc.

Start price
Target price
Perf. (%)
€137.98
05.06.22
€155.00
05.06.23
-7.09%
06.06.23

Could be worthwhile Investment >10% per year
buy
UnitedHealth Group Inc.

Start price
Target price
Perf. (%)
€471.15
17.05.22
-
17.05.23
-6.19%
17.05.23

Bristol-Myers Squibb

Start price
Target price
Perf. (%)
€72.88
16.05.22
-
16.05.23
-2.92%
27.05.22

Probably not worthwhile Investment
Business model of the past or high risk
buy
Gilead Sciences Inc

Start price
Target price
Perf. (%)
€59.87
15.05.22
€68.00
15.05.23
32.12%
28.10.22

Could be worthwhile Investment >10% per year
positive Cash Flow expected
ROE higher than 15% per year
Normal challenges to pay loans and raise capital
buy
Johnson & Johnson

Start price
Target price
Perf. (%)
€174.42
27.04.22
€190.00
27.04.23
-15.38%
27.04.23

Could be worthwhile Investment >10% per year
Market Leader or Top 3
Known brand
Future proof or reliable business model
buy
Intuitive Surgical Inc

Start price
Target price
Perf. (%)
€233.45
25.04.22
€250.00
25.04.23
14.61%
26.04.23

Could be worthwhile Investment >10% per year
Fair valuation
Some uniques
Higher risks for its business
buy
Pfizer Inc.

Start price
Target price
Perf. (%)
€50.65
07.04.22
€56.00
07.04.23
-24.58%
08.04.23

Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
High valuation
buy
Vertex Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€248.30
06.04.22
-
06.04.23
18.49%
06.04.23

buy
Regeneron Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€638.60
06.04.22
-
06.04.23
17.91%
06.04.23

buy
Pfizer Inc.

Start price
Target price
Perf. (%)
€46.84
04.04.22
€55.00
04.04.23
2.48%
16.04.22

Could be worthwhile Investment >10% per year
Top 10 in its market
Known brand
Small cyclical dependencies
buy
Bristol-Myers Squibb

Start price
Target price
Perf. (%)
€66.35
25.03.22
-
25.04.22
6.07%
26.04.22

Could be very worthwhile Investment >20% year
Revenue growth >5% per year expected
High dividend yield expected
Good rating
buy
Pfizer Inc.

Start price
Target price
Perf. (%)
€47.88
25.03.22
€64.00
25.03.23
-21.14%
27.03.23

Could be worthwhile Investment >10% per year
buy
Pfizer Inc.

Start price
Target price
Perf. (%)
€48.26
23.03.22
€55.00
23.03.23
-3.61%
02.04.22

Could be worthwhile Investment >10% per year
Top 10 in its market
Known brand
Small cyclical dependencies